This review describes research using the Promega BDNF Emax® ImmunoAssay System in a continuous medium-withdrawal method for measuring BDNF release from NMDA-treated neurons. This method was initially developed by Ann M. Marini and colleagues in 1998 in a landmark paper for ELISA-based neurotrophin detection.
Cell Notes 19, 6–7.
We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.
Ask us! We are here to help you.